JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva® in Mantle Cell Lymphoma in China

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

China ,Shanghai ,Hong Kong ,Chinese ,Chinj Hematol ,A Bristol Myers Squibb ,National Significant New Drug Development Program ,China National Medical Products Administration ,National Medical Products Administration ,Clearing Limited Hkex ,Drug Evaluation ,Breakthrough Therapy Designation ,Overall Survival ,Advanced Stage Mantle Cell ,Clinical Oncology ,Relmacabtagene Autoleucel Injection ,Juno Therapeutics ,Bristol Myers Squibb ,Hong Kong Exchanges ,Clearing Limited ,Business ,Health ,Pr Newswire ,Lymphoma ,